LimmaTech Biologics headquarters details
- Street address
- 3 Grabenstrasse
- City
- Schlieren
- State / region
- Kanton Zürich
- ZIP / postal code
- 8952
- Country
- Switzerland
- Phone
- +41 44 733 85 85
- Founded
- 2015
- Website
- lmtbio.com
Location map
Open in Google MapsAll LimmaTech Biologics office locations
| City | State / region | Country | Type |
|---|---|---|---|
| Schlieren HQ | Kanton Zürich | Switzerland | Headquarters |
About LimmaTech Biologics
LimmaTech Biologics is headquartered in Schlieren, Kanton Zürich, Switzerland. Founded in 2015, the company employs approximately 35 people worldwide.
Where is LimmaTech Biologics's main office?
LimmaTech Biologics's main headquarters office is located at 3 Grabenstrasse, Schlieren, Kanton Zürich 8952, Switzerland. This is the company's primary corporate address.
LimmaTech Biologics contact information
The main switchboard for LimmaTech Biologics headquarters can be reached at +41 44 733 85 85. Official website: lmtbio.com.
What does LimmaTech Biologics do?
LimmaTech Biologics AG is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. In addition to our proprietary research, we also develop vaccines together with GSK.
Frequently asked questions
Where is LimmaTech Biologics headquarters?
LimmaTech Biologics's headquarters is located at 3 Grabenstrasse, Schlieren, Kanton Zürich 8952, Switzerland.
What is LimmaTech Biologics's corporate address?
The corporate headquarters address is 3 Grabenstrasse, Schlieren, Kanton Zürich 8952, Switzerland.
When was LimmaTech Biologics founded?
LimmaTech Biologics was founded in 2015 and employs approximately 35 people.
What is LimmaTech Biologics's phone number?
The main phone number for LimmaTech Biologics headquarters is +41 44 733 85 85.
How many employees does LimmaTech Biologics have?
LimmaTech Biologics has approximately 35 employees (GraphIQ estimate, 2026).